The effect of vitamin D supplementation on bone metabolic markers in chronic kidney disease
Use of active forms of vitamin D is advocated in CKD patients for treatment of mineral bone disease because of the presumption that native forms of vitamin D would not undergo significant activation to calcitriol, the most active biological form of vitamin D. We present secondary analysis looking at...
Main Authors: | Yadav, A, Kumar, V, Banerjee, D, Gupta, K, Jha, V |
---|---|
Format: | Journal article |
Published: |
American Society for Bone and Mineral Research
2017
|
Similar Items
-
Effect of vitamin D supplementation on serum sclerostin levels in chronic kidney disease
by: Yadav, A, et al.
Published: (2018) -
Cholecalciferol supplementation and angiogenic markers in chronic kidney disease.
by: Jaskiran Kaur, et al.
Published: (2022-01-01) -
Cholecalciferol supplementation and angiogenic markers in chronic kidney disease
by: Jaskiran Kaur, et al.
Published: (2022-01-01) -
Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome
by: Aggarwal, A, et al.
Published: (2016) -
A randomized trial of vitamin D supplementation on vascular function in CKD
by: Kumar, V, et al.
Published: (2017)